Chu, X., Chang, X., Liu, S., Zhang, S., Xie, E., & Zhou, B. Phillyrin prevents calcium oxalate kidney stones through the PPARγ signaling pathway. Taylor & Francis Group.
Chicago Style (17th ed.) CitationChu, Xiaohan, Xingkang Chang, Shuaiqi Liu, Shengwei Zhang, Enxu Xie, and Bo Zhou. Phillyrin Prevents Calcium Oxalate Kidney Stones Through the PPARγ Signaling Pathway. Taylor & Francis Group.
MLA (9th ed.) CitationChu, Xiaohan, et al. Phillyrin Prevents Calcium Oxalate Kidney Stones Through the PPARγ Signaling Pathway. Taylor & Francis Group.
Warning: These citations may not always be 100% accurate.